Skip to main content
. 2019 Jun 24;53(5):289–297. doi: 10.4132/jptm.2019.06.07

Table 1.

Clinicopathologic characteristics of colorectal cancers according to SMAD4 expression

SMAD4-loss (n = 210, 16.4%) SMAD4-low (n = 942, 73.5%) SMAD4-high (n = 129, 10.1%) p for difference p for trend
Age (yr) 64 (27–83) 63 (20–90) 61 (25–93) .222
Sex .225 .105
 Male 132 (62.9) 566 (60.1) 69 (53.5)
 Female 78 (37.1) 376 (39.9) 60 (46.5)
Location < .001 .222
 Proximal 61 (29.1) 216 (22.9) 50 (38.8)
 Distal/Rectum 149 (70.9) 726 (77.1) 79 (61.2)
Gross type .002 < .001
 Fungating 122 (58.1) 624 (66.2) 99 (76.7)
 Infiltrative 88 (41.9) 318 (33.8) 30 (23.3)
pT category < .001 < .001
 pT1-2 20 (9.5) 176 (18.7) 37 (28.7)
 pT3-4 190 (90.5) 766 (81.3) 92 (71.3)
pN category < .001 < .001
 pN0 85 (40.5) 471 (50.0) 89 (69.0)
 pN1-2 125 (59.5) 471 (50.0) 40 (31.0)
Distant metastasis .001 .001
 M0 167 (79.5) 775 (82.3) 122 (94.6)
 M1 43 (20.5) 167 (17.7) 7 (5.4)
TNM stage < .001 < .001
 I, II 76 (36.2) 448 (47.6) 87 (67.4)
 III, IV 134 (63.8) 494 (52.4) 42 (32.6)
Lymphovascular invasion < .001 < .001
 Absent 97 (46.2) 543 (57.6) 96 (74.4)
 Present 113 (53.8) 399 (42.4) 33 (26.6)
Perineural invasion <.001 < .001
 Absent 133 (63.3) 730 (77.5) 113 (87.6)
 Present 77 (36.7) 212 (22.5) 16 (12.4)
Differentiation (grade) .612 .923
 Differentiated (G1/2) 200 (95.2) 906 (94.2) 122 (94.6)
 Undifferentiated (G3/4) 10 (4.8) 36 (3.8) 7 (5.4)
Tumor budding < .001 < .001
 Absent 48 (22.9) 256 (27.2) 57 (44.2)
 Present 162 (77.1) 686 (72.8) 72 (55.8)
Tumor-infiltrating lymphocytes (400 × magnification) < .001 < .001
 Low (< 8) 164 (78.1) 739 (78.4) 72 (55.8)
 High (≥ 8) 46 (21.9) 203 (21.6) 57 (44.2)
Mucin production .002 .581
 Absent 176 (83.8) 839 (89.1) 102 (79.1)
 Present 34 (16.2) 103 (10.9) 27 (20.9)

Values are presented as median (range) or number (%).